Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lifecore Biomedical, Inc. - Common Stock (NQ:LFCR)

8.090 UNCHANGED
Streaming Delayed Price Updated: 1:18 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 117,424
Open 8.120
Bid (Size) 8.090 (200)
Ask (Size) 8.160 (200)
Prev. Close 8.090
Today's Range 7.985 - 8.146
52wk Range 4.760 - 8.850
Shares Outstanding 29,456,705
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Important Notice to Long-Term Shareholders of CarMax, Inc. (NYSE: KMX); Inspire Medical Systems, Inc. (NYSE: INSP); Integer Holdings Corp. (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire

Performance

YTD
+21.5%
+21.5%
1 Month
+3.5%
+3.5%
3 Month
+9.9%
+9.9%
6 Month
+1.6%
+1.6%
1 Year
+9.0%
+9.0%

More News

Read More
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Earnings Scheduled For August 7, 2025 ↗
Via Benzinga
News headline image
Lifecore Biomedical Earnings Report: Q2 Overview ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Lifecore (LFCR) Q4 Revenue Beats 3% ↗
Via The Motley Fool
News headline image
Which stocks are experiencing notable movement on Friday? ↗
Via Chartmill
News headline image
Earnings Scheduled For January 2, 2025 ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Which stocks are gapping on Friday? ↗
Via Chartmill
News headline image
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For April 3, 2025 ↗
Via Benzinga
News headline image
Lifecore Biomedical Announces Special Stockholder Meeting
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus ↗
Via Benzinga
News headline image
Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday ↗
Via Benzinga
News headline image
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Nio, Li Auto And 3 Stocks To Watch Heading Into Thursday ↗
Via Benzinga
News headline image
S&P 500 Surges 23% In 2024, But Greed Index Remains In 'Fear' Zone ↗
Via Benzinga
Topics Stocks
News headline image
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
From Lifecore Biomedical, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Lifecore Biomedical, Inc. - Common Stock publicly traded?
Yes, Lifecore Biomedical, Inc. - Common Stock is publicly traded.
What exchange does Lifecore Biomedical, Inc. - Common Stock trade on?
Lifecore Biomedical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lifecore Biomedical, Inc. - Common Stock?
The ticker symbol for Lifecore Biomedical, Inc. - Common Stock is LFCR on the Nasdaq Stock Market
What is the current price of Lifecore Biomedical, Inc. - Common Stock?
The current price of Lifecore Biomedical, Inc. - Common Stock is 8.090
When was Lifecore Biomedical, Inc. - Common Stock last traded?
The last trade of Lifecore Biomedical, Inc. - Common Stock was at 12/31/25 01:18 PM ET
What is the market capitalization of Lifecore Biomedical, Inc. - Common Stock?
The market capitalization of Lifecore Biomedical, Inc. - Common Stock is 238.30M
How many shares of Lifecore Biomedical, Inc. - Common Stock are outstanding?
Lifecore Biomedical, Inc. - Common Stock has 238M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.